Graphique du cours de l'action ONCO
ONCO Dividendes
Onconetix Inc
$0.95
-11.52%
$-0.12
À la fermeture : Jul 02, 16:00:00 GMT-4
$0.94
-1.62%
$-0.01
Post-Marché: Jul 02, 20:00:00 GMT-4
Retour
Onconetix Inc (ONCO) Dividendes
Statistiques clés
Clôture préc.
$1.08
Prix d'ouverture
$1.1
Plage de la journée
$0.93 - $1.1
Plage de 52 semaines
$0.91 - $361.5
Volume
386.5K
Volume moyen
857.7K
Rendement en dividend
--
BPA (TTM)
-219.70
Capitalisation boursière
$1.0M
Qu’est-ce que ONCO ?
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company is headquartered in Cincinnati, Ohio and currently employs 2 full-time employees. The company went IPO on 2022-02-18. The firm owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.
Fonctionnalités
© 2026 Edgen fonctionné par
